Medical Journals

Biliary Obstruction Selectively Expands and Activates Liver Myeloid Dendritic Cells.

Authors:
  • Bleier Joshua I
  • Katz Steven C
  • Chaudhry Umer I
  • Pillarisetty Venu G
  • Kingham T Peter
  • Shah Alaap B
  • Raab Jesse R
  • DeMatteo Ronald P

From: Hepatobiliary Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Journal of immunology (Baltimore, Md. : 1950)

  • Publish Date: Jun 2006
  • ISSN: 0022-1767
  • Volume: 176
  • Issue: 12
  • Pages: 7189-95
  • Medium: Print
  • Language: English
  • Citation (JAMA): Bleier Joshua I, Katz Steven C, Chaudhry Umer I, et al. Biliary Obstruction Selectively Expands and Activates Liver Myeloid Dendritic Cells.. J. Immunol. Jun 2006;176:7189-95

Abstract

Obstructive jaundice is associated with immunologic derangements and hepatic inflammation and fibrosis. Because dendritic cells (DCs) play a major role in immune regulation, we hypothesized that the immunosuppression associated with jaundice may result from the functional impairment of liver DCs. We found that bile duct ligation (BDL) in mice expanded the myeloid subtype of liver DCs from 20 to 80% of total DCs and increased their absolute number by >15-fold. Liver myeloid DCs following BDL, but not sham laparotomy, had increased Ag uptake in vivo, high IL-6 secretion in response to LPS, and enhanced ability to activate T cells. The effects of BDL were specific to liver DCs, as spleen DCs were not affected. Expansion of liver myeloid DCs depended on Gr-1(+) cells, and we implicated monocyte chemotactic protein-1 as a potential mediator. Thus, obstructive jaundice selectively expands liver myeloid DCs that are highly functional and unlikely to be involved with impaired host immune responses.

Mesh Headings (Keywords): Animals, Cell Count, Cell Proliferation, Cells, Cultured, Cholestasis, Dendritic Cells, Jaundice, Obstructive, Ligation, Lipopolysaccharides, Liver, Lymphocyte Activation, Male, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Knockout, Mice, Transgenic, Myeloid Cells, Receptors, Chemokine, T-Lymphocytes


Check for Full Text / PubMed Unique Identifier (PMID): 16751362


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.